BRIEF-Furiex Pharma jumps in premarket after FDA ok's new drug treatments for type 2 diabetes

NEW YORK Mon Jan 28, 2013 8:37am EST

NEW YORK Jan 28 (Reuters) - Furiex Pharmaceuticals Inc : * Furiex Pharma jumps 34.2 percent to $28.50 in premarket after FDA OK's new Takeda Pharmaceutical's drug treatments for type 2 diabetes, resulting in milestone payments for Furiex

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.